Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Anti-Cancer Drug Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Avastin
  • 1.3.3 Rituxan
  • 1.3.4 Herceptin
  • 1.3.5 Alimta
• 1.4 Market Segment by Application
  • 1.4.1 Global Anti-Cancer Drug Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Clinic
  • 1.4.4 Home Care
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-Cancer Drug Market Size
  • 2.1.1 Global Anti-Cancer Drug Revenue 2014-2025
  • 2.1.2 Global Anti-Cancer Drug Sales 2014-2025
• 2.2 Anti-Cancer Drug Growth Rate by Regions
  • 2.2.1 Global Anti-Cancer Drug Sales by Regions 2014-2019
  • 2.2.2 Global Anti-Cancer Drug Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Anti-Cancer Drug Sales by Manufacturers
  • 3.1.1 Anti-Cancer Drug Sales by Manufacturers 2014-2019
  • 3.1.2 Anti-Cancer Drug Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Anti-Cancer Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Anti-Cancer Drug Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Anti-Cancer Drug Market Concentration Ratio (CR5 and HHI)
• 3.3 Anti-Cancer Drug Price by Manufacturers
• 3.4 Key Manufacturers Anti-Cancer Drug Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Anti-Cancer Drug Market
• 3.6 Key Manufacturers Anti-Cancer Drug Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Avastin Sales and Revenue (2014-2019)
  • 4.1.2 Rituxan Sales and Revenue (2014-2019)
  • 4.1.3 Herceptin Sales and Revenue (2014-2019)
  • 4.1.4 Alimta Sales and Revenue (2014-2019)
• 4.2 Global Anti-Cancer Drug Sales Market Share by Type
• 4.3 Global Anti-Cancer Drug Revenue Market Share by Type
• 4.4 Anti-Cancer Drug Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Anti-Cancer Drug Sales by Application

6 United States

• 6.1 United States Anti-Cancer Drug Breakdown Data by Company
• 6.2 United States Anti-Cancer Drug Breakdown Data by Type
• 6.3 United States Anti-Cancer Drug Breakdown Data by Application

7 European Union

• 7.1 European Union Anti-Cancer Drug Breakdown Data by Company
• 7.2 European Union Anti-Cancer Drug Breakdown Data by Type
• 7.3 European Union Anti-Cancer Drug Breakdown Data by Application

8 China

• 8.1 China Anti-Cancer Drug Breakdown Data by Company
• 8.2 China Anti-Cancer Drug Breakdown Data by Type
• 8.3 China Anti-Cancer Drug Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Anti-Cancer Drug Breakdown Data by Company
• 9.2 Rest of World Anti-Cancer Drug Breakdown Data by Type
• 9.3 Rest of World Anti-Cancer Drug Breakdown Data by Application
• 9.4 Rest of World Anti-Cancer Drug Breakdown Data by Countries
  • 9.4.1 Rest of World Anti-Cancer Drug Sales by Countries
  • 9.4.2 Rest of World Anti-Cancer Drug Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Merck
  • 10.1.1 Merck Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.1.4 Anti-Cancer Drug Product Introduction
  • 10.1.5 Merck Recent Development
• 10.2 Bristol-Myers Squibb
  • 10.2.1 Bristol-Myers Squibb Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.2.4 Anti-Cancer Drug Product Introduction
  • 10.2.5 Bristol-Myers Squibb Recent Development
• 10.3 Bayer
  • 10.3.1 Bayer Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.3.4 Anti-Cancer Drug Product Introduction
  • 10.3.5 Bayer Recent Development
• 10.4 GlaxoSmithKline
  • 10.4.1 GlaxoSmithKline Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.4.4 Anti-Cancer Drug Product Introduction
  • 10.4.5 GlaxoSmithKline Recent Development
• 10.5 Novartis
  • 10.5.1 Novartis Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.5.4 Anti-Cancer Drug Product Introduction
  • 10.5.5 Novartis Recent Development
• 10.6 Sanofi
  • 10.6.1 Sanofi Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.6.4 Anti-Cancer Drug Product Introduction
  • 10.6.5 Sanofi Recent Development
• 10.7 Pfizer
  • 10.7.1 Pfizer Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.7.4 Anti-Cancer Drug Product Introduction
  • 10.7.5 Pfizer Recent Development
• 10.8 Amgen
  • 10.8.1 Amgen Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.8.4 Anti-Cancer Drug Product Introduction
  • 10.8.5 Amgen Recent Development
• 10.9 Celgene Corporation
  • 10.9.1 Celgene Corporation Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.9.4 Anti-Cancer Drug Product Introduction
  • 10.9.5 Celgene Corporation Recent Development
• 10.10 Ariad Pharmaceuticals
  • 10.10.1 Ariad Pharmaceuticals Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Anti-Cancer Drug
  • 10.10.4 Anti-Cancer Drug Product Introduction
  • 10.10.5 Ariad Pharmaceuticals Recent Development
• 10.11 Eli Lilly
• 10.12 Hoffmann-La Roche Ltd.
• 10.13 AstraZeneca
• 10.14 Boehringer Ingelheim GmbH
• 10.15 Teva Pharmaceuticals

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Anti-Cancer Drug Sales Channels
  • 11.2.2 Anti-Cancer Drug Distributors
• 11.3 Anti-Cancer Drug Customers

12 Market Forecast

• 12.1 Global Anti-Cancer Drug Sales and Revenue Forecast 2019-2025
• 12.2 Global Anti-Cancer Drug Sales Forecast by Type
• 12.3 Global Anti-Cancer Drug Sales Forecast by Application
• 12.4 Anti-Cancer Drug Forecast by Regions
  • 12.4.1 Global Anti-Cancer Drug Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Anti-Cancer Drug Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.
Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.
In 2019, the market size of Anti-Cancer Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Cancer Drug.

This report studies the global market size of Anti-Cancer Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Cancer Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Merck
Bristol-Myers Squibb
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche Ltd.
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceuticals

Market Segment by Product Type
Avastin
Rituxan
Herceptin
Alimta

Market Segment by Application
Hospital
Clinic
Home Care

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Anti-Cancer Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Cancer Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Anti-Cancer Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025